Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
4.280
-0.070 (-1.61%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Molecular Partners AG Employees
Molecular Partners AG had 134 employees as of December 31, 2025. The number of employees decreased by 25 or -15.46% compared to the previous year.
Employees
134
Change (1Y)
-25
Growth (1Y)
-15.46%
Revenue / Employee
n/a
Profits / Employee
-$580,216
Market Cap
159.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| Fate Therapeutics | 161 |
| Alps Group | 93 |
| Agenus | 81 |
| Tenaya Therapeutics | 70 |
| Spero Therapeutics | 25 |
| Tiziana Life Sciences | 9 |
| Galectin Therapeutics | 9 |
MOLN News
- 9 days ago - Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712 - GlobeNewsWire
- 14 days ago - Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting - GlobeNewsWire
- 5 weeks ago - Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors - GlobeNewsWire
- 5 weeks ago - Molecular Partners Presents New Preclinical Data Highlighting Radio-DARPins' Amenability to Multiple Isotopes - GlobeNewsWire
- 6 weeks ago - Molecular Partners to Hold Three Poster Presentations at AACR 2026 - GlobeNewsWire
- 6 weeks ago - Molecular Partners Reports Highlights and Financial Results for Full Year 2025 - GlobeNewsWire
- 2 months ago - Molecular Partners Announces Participation in March Investor Conferences and Upcoming 2025 Financial Results - GlobeNewsWire
- 3 months ago - Molecular Partners AG Transcript: Study update - Transcripts